Report
Share
Recommended
تصنيف العناصر في الجدول الدوري الحديث
The document explains how elements are organized in the periodic table based on their atomic number and resulting physical and chemical properties. Elements are arranged in periods and groups, with elements in the same group having similar properties. Key groups mentioned include alkali metals, halogens, noble gases, and transition metals. The periodic table is used to predict electron configurations and the relationship between an element's position and its chemical behavior.
Recommended
تصنيف العناصر في الجدول الدوري الحديث
The document explains how elements are organized in the periodic table based on their atomic number and resulting physical and chemical properties. Elements are arranged in periods and groups, with elements in the same group having similar properties. Key groups mentioned include alkali metals, halogens, noble gases, and transition metals. The periodic table is used to predict electron configurations and the relationship between an element's position and its chemical behavior.
اولى اعدادى جغرافيا-- Pro 2016
اولى جغرافيا الصف الاول الاعدادى - ترم اول - تعديل 2016 - نسخه تجريبية
Phaeocystis-antarctica-transcriptomics-AM
My master's thesis project presentation on Transcriptomics of Iron Limitation in Phaeocystis antarctica supervised by Assist. Prof. Ahmed Moustafa (who surprised me with slide 2 :)
Mrr cmb journal_club_20111115
FIP1/RCP Binding to Golgin-97 Regulates Retrograde Transport from Recycling Endosomes to the trans-Golgi Network - Mol. Biol. Cell. 2010 21(17): 3041 – 3053
Mrr iti phar_mu
This document summarizes a graduation project that involved creating a database called PharMu to explore relationships between resident microbes, drugs, and human body sites. The project involved mining existing literature to extract known microbe-drug interactions and curating the data to create a relational database. Functionalities included search capabilities and an admin backend. Future work includes deployment on a public server and integrating additional data sources and classification hierarchies.
Mrr iti pm_poster
This document describes the PharmacoMicrobiomics Database project, which aims to build an educational web portal and knowledge base exploring the effects of the human microbiome on drugs. The database collects data on known microbe-drug interactions from literature and classifies it according to drug class, microbe family, and body site. It was developed using a MySQL database managed through the Django framework. Future directions include connecting to public databases through BioPython, annually updating data by parsing MeSH keywords, and expanding the database schema and cloud infrastructure. The project aims to introduce microbiome concepts to pharmacy students and benefit research.
Mrr 05152011 pmdb_proposal
The document outlines the Pharmacomicrobiomics Database (PMDB) project, which aims to catalog interactions between drugs and the human microbiome. It discusses how the Human Genome Project and Human Microbiome Project motivated the new field of pharmacomicrobiomics. The PMDB will be a MySQL database containing information on drugs, microbial strains, body sites, pathways, and publications. So far, the team has developed a proposed database structure and website, published two papers on pharmacomicrobiomics, and recruited students to help curate data.
Forex-ITI-Intake31
This document provides an introduction to forex trading. It explains that forex involves trading one currency for another on global markets. The forex market is the largest financial market in the world, with over $4 trillion traded daily. Individual investors can participate by opening positions using leverage, which allows trading much larger amounts than the initial investment. The document outlines the basics of how forex markets work, how to profit by buying low and selling high, and the advantages of forex such as its 24/7 availability and ability to leverage funds. Risks are addressed, noting that losses are limited to the initial investment if proper risk management is followed.
Team 4
This document is a report from Team 4 about marketing the drug Pluto, a second-line treatment for chronic myeloid leukemia produced by Novartis, in Egypt. The team aims to become the second highest ranking drug in the market within 5 years by investing 660,000 Egyptian pounds and gaining a profit of 4,320,000 pounds in the first year, with a 10% annual profit increase. Their strategy involves increasing market share and targeted patients through various marketing activities while lowering the price after achieving certain thresholds. They will evaluate their progress using financial and qualitative key performance indicators.
More Related Content
Viewers also liked
اولى اعدادى جغرافيا-- Pro 2016
اولى جغرافيا الصف الاول الاعدادى - ترم اول - تعديل 2016 - نسخه تجريبية
Viewers also liked (14)
More from Mariam Reyad
Phaeocystis-antarctica-transcriptomics-AM
My master's thesis project presentation on Transcriptomics of Iron Limitation in Phaeocystis antarctica supervised by Assist. Prof. Ahmed Moustafa (who surprised me with slide 2 :)
Mrr cmb journal_club_20111115
FIP1/RCP Binding to Golgin-97 Regulates Retrograde Transport from Recycling Endosomes to the trans-Golgi Network - Mol. Biol. Cell. 2010 21(17): 3041 – 3053
Mrr iti phar_mu
This document summarizes a graduation project that involved creating a database called PharMu to explore relationships between resident microbes, drugs, and human body sites. The project involved mining existing literature to extract known microbe-drug interactions and curating the data to create a relational database. Functionalities included search capabilities and an admin backend. Future work includes deployment on a public server and integrating additional data sources and classification hierarchies.
Mrr iti pm_poster
This document describes the PharmacoMicrobiomics Database project, which aims to build an educational web portal and knowledge base exploring the effects of the human microbiome on drugs. The database collects data on known microbe-drug interactions from literature and classifies it according to drug class, microbe family, and body site. It was developed using a MySQL database managed through the Django framework. Future directions include connecting to public databases through BioPython, annually updating data by parsing MeSH keywords, and expanding the database schema and cloud infrastructure. The project aims to introduce microbiome concepts to pharmacy students and benefit research.
Mrr 05152011 pmdb_proposal
The document outlines the Pharmacomicrobiomics Database (PMDB) project, which aims to catalog interactions between drugs and the human microbiome. It discusses how the Human Genome Project and Human Microbiome Project motivated the new field of pharmacomicrobiomics. The PMDB will be a MySQL database containing information on drugs, microbial strains, body sites, pathways, and publications. So far, the team has developed a proposed database structure and website, published two papers on pharmacomicrobiomics, and recruited students to help curate data.
Forex-ITI-Intake31
This document provides an introduction to forex trading. It explains that forex involves trading one currency for another on global markets. The forex market is the largest financial market in the world, with over $4 trillion traded daily. Individual investors can participate by opening positions using leverage, which allows trading much larger amounts than the initial investment. The document outlines the basics of how forex markets work, how to profit by buying low and selling high, and the advantages of forex such as its 24/7 availability and ability to leverage funds. Risks are addressed, noting that losses are limited to the initial investment if proper risk management is followed.
Team 4
This document is a report from Team 4 about marketing the drug Pluto, a second-line treatment for chronic myeloid leukemia produced by Novartis, in Egypt. The team aims to become the second highest ranking drug in the market within 5 years by investing 660,000 Egyptian pounds and gaining a profit of 4,320,000 pounds in the first year, with a 10% annual profit increase. Their strategy involves increasing market share and targeted patients through various marketing activities while lowering the price after achieving certain thresholds. They will evaluate their progress using financial and qualitative key performance indicators.
Team 5
This document outlines a strategic plan to launch Pluto, a second generation tyrosine kinase inhibitor for treating adult CML patients resistant or intolerant to prior therapies. The plan's objectives are to make Pluto the first choice treatment for 60% of imatinib-resistant/intolerant cases, increasing to 80% within 5 years, and achieve a 6:1 return on investment within 5 years. The implementation strategy involves pricing Pluto at 1500 LE/month, targeting hematologists and oncologists through marketing and allocating 1.9 million LE for implementation and advertising over 2 years in Egypt.
Team 3
Pluto® is a new drug that targets CML patients resistant or intolerant to existing treatments. It is 100 LE less than competitors, acts faster, and binds more effectively to the disease target. The business plan aims to introduce Pluto®, gain an 80% market share within 5 years, and achieve a 7.9% return on investment. A differentiated marketing strategy will promote Pluto® to top hematologists and oncologists. Sales, market share, and patient satisfaction will be tracked to evaluate the strategy's success in providing an effective new treatment option.
Team 2
Pluto is a new drug launched by Novartis for resistant and intolerant chronic myeloid leukemia (CML) patients. The goal is to achieve 75% market share within 5 years. Pluto is effective for resistant CML and for patients who cannot tolerate existing treatments. The strategic plan includes increasing awareness of CML, providing psychological support for patients, and making the drug affordable for poor patients through fundraising and discount programs.
Team1
This document presents a strategic business plan for Pluto®, a new CML drug intended for patients resistant or intolerant to first-line treatments. The plan estimates the target market size as 20% of 1600 patients with CML in Egypt, or 320 patients. The team aims to capture 65% market share in the first year, equivalent to sales of 3.5-4 million Egyptian pounds. Over the first 5 years, total sales are projected to reach around 20 million pounds. The SWOT analysis identifies Pluto's advantages in efficacy, safety profile and addressing an unmet medical need for resistant/intolerant patients. The strategic objectives include achieving specific targets for patient acquisition, brand awareness, market share, customer satisfaction,
MRR_Harris_JC_20100217
This IS my first power-point presentation, presenting at the Journal Club Harris et al's paper from Science entitled: "Evolution of MRSA During Hospital Transmission and Intercontinental Spread" Many thanks to Dr. Ramy A. for the choice and the fulltext and Dr. Tamer I. for the opportunity, encouragement and great help.
More from Mariam Reyad (13)
Nardeen nagy the play_2010
- 1. كنيسة السيدة العذراء و الانبا أبرام - فيصل فرع مارمرقس بنات اعدادى
- 3. اشترك فى هذا العمل : مادونا البير : الرجل الدجال ( سباخ ) مارينا عادل : شمروخ جيهان عبده : قائد الجيوش
- 4. بسمة رفعت : التاريخ ميرنا رفعت : الملك قسطنطين
- 5. دينا رفعت : حراس مريم غالى :
- 6. الوزير : مارينا اشرف الملكة هيلانة : ميلسيا جرجس
- 7. الوصيفة 1 : مارينا مرزق الوصيفة 2 : ميرنا عماد المنادى : ناردين ناجى
- 8. مارينا ايهاب : الطباخة ساندى فريد : الرجل العجوز مارينا عادل : الميت
- 9. داليا عماد : ديكوووووووووووووور مارينا يوسف :
- 10. Thank You… Hope you had enjoyed our play .. Music prepared by : T. Mariam Reyad Accessories and clothes by: T. Seham
- 11. T. Nermin Samir Directed by :